INTERCEPT PHARMACEUTICALS IN - NOTE 3.500% 2/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2022 to Q4 2023

Type / Class
Debt / NOTE 3.500% 2/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INTERCEPT PHARMACEUTICALS IN - NOTE 3.500% 2/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2023 Q4 $0 $0 -$118,876,480 0
2023 Q3 $111,143,000 $118,876,480 +$493,796 107.16% 6
2023 Q2 $111,143,000 $106,386,571 96.0% 6
2023 Q1 $111,143,000 $114,477,407 +$71,678 103.31% 6
2022 Q4 $111,223,000 $108,345,877 -$1,574,076 100.64% 10
2022 Q3 $111,223,000 $114,976,000 +$114,976,000 102.91% 9